Uptake and release phenomena in contact lens care by silicone hydrogel lenses

Eye and Contact Lens

Volumn 39, Issue 1, 2013, Pages 29-36

  Jones, Lyndon ^a   Powell, Charles H ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b Advanced Medical Optics Inc   (United States)

Author keywords

Biocide; Contact lens solutions; lens; Preservatives; Silicone hydrogel; Uptake and release

Indexed keywords

BIOCIDE;

CELL STRUCTURE; CONFERENCE PAPER; CONTACT LENS; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MIXTURE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LIPOPHILICITY; MOLECULAR SIZE; MOLECULAR WEIGHT; POROSITY; PRIORITY JOURNAL; SILICONE HYDROGEL LENS; WATER CONTENT; WETTABILITY;

CONTACT LENSES, HYDROPHILIC; DISINFECTANTS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; PHARMACEUTICAL PREPARATIONS; PRESERVATIVES, PHARMACEUTICAL; SILICONES;

EID: 84873100190     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0b013e31827d4f25     Document Type: Conference Paper

References (76)

1. Morgan PB, Woods C, Tranoudis I, et al. International contact lens prescribing in 2011. Contact Lens Spectrum 2012;27:26-31.
2. Morgan PB, Efron N, Helland M, et al. Global trends in prescribing contact lenses for extended wear. Cont Lens Anterior Eye 2011;34:32-35.
3. Stapleton F, Stretton S, Papas E, et al. Silicone hydrogel contact lenses and the ocular surface. Ocul Surf 2006;4:24-43.
4. Sweeney D, du Toit R, Keay L, et al. Clinical performance of silicone hydrogel lenses. In: Sweeney D, ed. Silicone Hydrogels: Continuous Wear Contact Lenses. Oxford, United Kingdom, Butterworth-Heinemann, 2004, pp 164-216.
5. Karlgard CC, Jones LW, Moresoli C. Survey of bandage lens use in North America, OctoberYDecember 2002. Eye Contact Lens 2004;30:25-30.
6. Tian X, Iwatsu M, Sado K, et al. Studies on the uptake and release of fluoroquinolones by disposable contact lenses. CLAO J 2001;27:216-220.
7. Karlgard CC, Jones LW, Moresoli C. Ciprofloxacin interaction with siliconbased and conventional hydrogel contact lenses. Eye Contact Lens 2003;29: 83-89.
8. Hui A, Boone A, Jones L. Uptake and release of ciprofloxacinYHCl from conventional and silicone hydrogel contact lens materials. Eye Contact Lens 2008;34:266-271.
9. Karlgard CC, Wong NS, Jones LW, et al. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141-151.
10. Soluri A, Hui A, Jones L. Delivery of ketotifen fumarate by commercial contact lens materials. Optom Vis Sci 2012;89:1140-1149.
11. Boone A, Hui A, Jones L. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens 2009;35:260-267.
12. Schultz CL, Morck DW. Contact lenses as a drug delivery device for epidermal growth factor in the treatment of ocular wounds. Clin Exp Optom 2010;93:61-65.
13. Peng CC, Ben-Shlomo A, Mackay EO, et al. Drug delivery by contact lens in spontaneously glaucomatous dogs. Curr Eye Res 2012;37:204-211.
14. Plaut BS, Davies DJ, Meakin BJ, et al. The mechanism of interaction between chlorhexidine digluconate and poly(2-hydroxyethyl methacrylate). J Pharm Pharmacol 1981;33:82-88.
15. Cioletti K. Determination of thimerosal content in contact lens polymers. Int Cont Lens Clin 1980;1/2:16-20.
16. Coward BD, Neumann R, Callender M. Solution intolerance among users of four chemical soft lens care regimens. Am J Optom Physiol Opt 1984;61: 523-527.
17. Mondino BJ, Groden LR. Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol 1980;98: 1767-1770.
18. Mondino BJ, Salamon SM, Zaidman GW. Allergic and toxic reactions of soft contact lens wearers. Surv Ophthalmol 1982;26:337-344.
19. Udell IJ, Mannis MJ, Meisler DM, et al. Pseudodendrites in soft contact lens wearers. CLAO J 1985;11:51-53.
20. Frantz JM, Saloom RJ, Green MT, et al. Lesions resembling trantas dots in a patient wearing soft contact lenses. Am J Ophthalmol 1987;104:305-306.
21. Wilson LA, McNatt J, Reitschel R. Delayed hypersensitivity to thimerosal in soft contact lens wearers. Ophthalmology 1981;88:804-809.
22. Rietschel RL, Wilson LA. Ocular inflammation in patients using soft contact lenses. Arch Dermatol 1982;118:147-149.
23. Sendele DD, Kenyon KR, Mobilia EF, et al. Superior limbic keratoconjunctivitis in contact lens wearers. Ophthalmology 1983;90:616-622.
24. Cai F, Backman HA, Baines MG. Thimerosal: An ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity. Curr Eye Res 1988;7:341-351.
25. Jones L, Senchyna M. Soft contact lens solutions review: Part 1-components of modern care regimens. Optom Pract 2007;8:45-56.
26. Jones L, Christie C. Soft contact lens solutions review: Part 2-modern generation care systems. Optom Pract 2008;9:43-62.
27. Rosenthal RA, Dassanayake NL, Schlitzer RL, et al. Biocide uptake in contact lenses and loss of fungicidal activity during storage of contact lenses. Eye Contact Lens 2006;32:262-266.
28. Warburton K, Noble-Wang J, Henry B, et al. Absorption of alexidine by contact lenses and lens cases and its effects on disinfection efficacy against Fusarium solani. American Society for Microbiology. Available at: www. fda.gov/downloads/MedicalDevices/./UCM130756.ppt, 2007.
29. Levy B, Heiler D, Norton S. Report on testing from an investigation of fusarium keratitis in contact lens wearers. Eye Contact Lens 2006;32: 256-261.
30. Chalmers RL, Wagner H, Mitchell GL, et al. Age and other risk factors for corneal infiltrative and inflammatory events in young soft contact lens wearers from the Contact Lens Assessment in Youth (CLAY) study. Invest Ophthalmol Vis Sci 2011;52:6690-6696.
31. Chalmers RL, Keay L, McNally J, et al. Multicenter caseYcontrol study of the role of lens materials and care products on the development of corneal infiltrates. Optom Vis Sci 2012;89:316-325.
32. Radford CF, Minassian D, Dart JK, et al. Risk factors for nonulcerative contact lens complications in an ophthalmic accident and emergency department: A caseYcontrol study. Ophthalmology 2009;116:385-392.
33. Jones L, MacDougall N, Sorbara LG. Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen. Optom Vis Sci 2002;79:753-761.
34. Garofalo RJ, Dassanayake N, Carey C, et al. Corneal staining and subjective symptoms with multipurpose solutions as a function of time. Eye Contact Lens 2005;31:166-174.
35. Dumbleton K, Keir N, Moezzi A, et al. Objective and subjective responses in patients refitted to daily-wear silicone hydrogel contact lenses. Optom Vis Sci 2006;83:758-768.
36. Andrasko G, Ryen K. A series of evaluations of MPS and silicone hydrogel lens combinations. Rev Cornea Contact Lens 2007;143:36-42.
37. Carnt N, Jalbert I, Stretton S, et al. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation. Optom Vis Sci 2007;84: 309-315.
38. Andrasko G, Ryen K. Corneal staining and comfort observed with traditional and silicone hydrogel lenses and multipurpose solution combinations. Optometry 2008;79:444-454.
39. Carnt NA, Evans VE, Naduvilath TJ, et al. Contact lens-related adverse events and the silicone hydrogel lenses and daily wear care system used. Arch Ophthalmol 2009;127:1616-1623.
40. Young G, Keir N, Hunt C, et al. Clinical evaluation of long-term users of two contact lens care preservative systems. Eye Contact Lens 2009;35:50-58.
41. Efron N. Putting vital stains in context. Clin Exp Optom [published online ahead of print October 10, 2012]. doi: 10.1111/j.1444-0938.2012.00802.x.
42. Willcox MD, Harmis N, Cowell BA, et al. Bacterial interactions with contact lenses; effects of lens material, lens wear and microbial physiology. Biomaterials 2001;22:3235-3247.
43. Szczotka-Flynn L, Lass JH, Sethi A, et al. Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses. Invest Ophthalmol Vis Sci 2010;51:5421-5430.
44. Fletcher EL, Fleiszig SM, Brennan NA. Lipopolysaccharide in adherence of Pseudomonas aeruginosa to the cornea and contact lenses. Invest Ophthalmol Vis Sci 1993;34:1930-1936.
45. Zorko M, Jerala R. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J Antimicrob Chemother 2008;62:730-737.
46. Simmons PA, Donshik PC, Kelly WF, et al. Conditioning of hydrogel lenses by a multipurpose solution containing an ocular lubricant. CLAO J 2001;27:192-194.
47. Ketelson HA, Meadows DL, Stone RP. Dynamic wettability properties of a soft contact lens hydrogel. Colloids Surf B Biointerfaces 2005;40:1-9.
48. Scheuer CA, Fridman KM, Barniak VL, et al. Retention of conditioning agent hyaluronan on hydrogel contact lenses. Cont Lens Anterior Eye 2010: 33(Suppl 1):S2-S6.
49. Lorentz H, Rogers R, Jones L. The impact of lipid on contact angle wettability. Optom Vis Sci 2007;84:946-953.
50. Maldonado-Codina C, Morgan PB. In vitro water wettability of silicone hydrogel contact lenses determined using the sessile drop and captive bubble techniques. J Biomed Mater Res A 2007;83:496-502.
51. Tighe B. Silicone hydrogels: Structure, properties and behaviour. In: Sweeney D, ed. Silicone Hydrogels: Continuous Wear Contact Lenses. Oxford, United Kingdom, Butterworth-Heinemann, 2004, pp 1-27.
52. Powell CH, Lally JM, Hoong LD, et al. Lipophilic versus hydrodynamic modes of uptake and release by contact lenses of active entities used in multipurpose solutions. Cont Lens Anterior Eye 2010;33:9-18.
53. Stone R. Why contact lens groups? Contact Lens Spectrum 1988;3:38-41.
54. Premarket notification [510(k)] guidance document for class II daily wear contact lenses, FDA. Available at: http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm080928.htm. Accessed August 17, 2012.
55. Sack RA, Jones B, Antignani A, et al. Specificity and biological activity of the protein deposited on the hydrogel surface. Relationship of polymer structure to biofilm formation. Invest Ophthalmol Vis Sci 1987;28: 842-849.
56. Minarik L, Rapp J. Protein deposits on individual hydrophilic contact lenses: Effects of water and ionicity. CLAO J 1989;15:185-188.
57. Prager MD, Quintana RP. Radiochemical studies on contact lens soilation. I. Lens uptake of 14C-lysozyme from simple and complex artificial tear solutions. J Biomed Mater Res 1997;36:119-124.
58. Garrett Q, Garrett RW, Milthorpe BK. Lysozyme sorption in hydrogel contact lenses. Invest Ophthalmol Vis Sci 1999;40:897-903.
59. Luensmann D, Jones L. Protein deposition on contact lenses: The past, the present, and the future. Cont Lens Anterior Eye 2012;35:53-64.
60. Subbaraman LN, Glasier MA, Senchyna M, et al. Kinetics of in vitro lysozyme deposition on silicone hydrogel, PMMA, and FDA groups I, II, and IV contact lens materials. Curr Eye Res 2006;31:787-796.
61. Jones L, Davies I, Jones D. Effect of hydrogen peroxide neutralisation on the fitting characteristics of group IV disposable contact lenses. J Br Contact Lens Assoc 1993;16:135-140.
62. International Organization for Standardization. Ophthalmic Optics - Contact Lenses Part 1 - Vocabulary, Classification System Recommendations Labelling Specifications, ISO 18369-1:2006/Amd 1:2009. Geneva, Switzerland, International Orginaztions for Standardization, 2009.
63. Suwala M, Glasier MA, Subbaraman LN, et al. Quantity and conformation of lysozyme deposited on conventional and silicone hydrogel contact lens materials using an in vitro model. Eye Contact Lens 2007;33:138-143.
64. Kilvington S, Huang L, Kao E, et al. Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance. J Optom 2010;3:134-142.
65. Carney FP, Nash WL, Sentell KB. The adsorption of major tear film lipids in vitro to various silicone hydrogels over time. Invest Ophthalmol Vis Sci 2008;49:120-124.
66. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54:3-12.
67. Sentell K, Beaullieu E. Comparison of preservative uptake and release profiles of PHMB from soft contact lens care products by silicone hydrogel contact lenses. ARVO abstracts 2004. Fort Lauderdale, Florida, ARVO conference, May 2004, e-abstract # 1573.
68. Dassanayake N, Garofalo R, Carey C, et al. Correlating biocide uptake and release profiles with corneal staining and subjective symptoms. ARVO abstracts 2005. Fort Lauderdale, Florida, ARVO conference, May 2005, e-abstract #915.
69. Bright FV, Merchea MM, Kraut ND, et al. A preservative-and-fluorescein interaction model for benign multipurpose solution-associated transient corneal hyperfluorescence. Cornea 2012;31:1480-1488.
70. Cole N, Garthwaite L, Chen R, et al. Effect of multipurpose solutions on cell morphology and cytokine production by corneal epithelial cells. Optom Vis Sci 2012;89:1460-1467.
71. Green JA, Phillips KS, Hitchins VM, et al. Material properties that predict preservative uptake for silicone hydrogel contact lenses. Eye Contact Lens 2012;38:350-357.
72. Diec J, Evans VE, Tilia D, et al. Comparison of ocular comfort, vision, and SICS during silicone hydrogel contact lens daily wear. Eye Contact Lens 2012;38:2-6.
73. Carnt N, Evans V, Holden B, et al. IER matrix update: Adding another silicone hydrogel. Contact Lens Spectrum 2008;23:28-35.
74. Andrasko G. Solution-induced staining and comfort during lens wear. Contact Lens Spectrum 2008;23:33-35.
75. Lorentz H, Heynen M, Trieu D, et al. The impact of tear film components on in vitro lipid uptake. Optom Vis Sci 2012;89:856-867.
76. Mohammadi S, Gorbet M. Design and development of an in vitro tear replenishment system. ARVO abstracts 2012. Fort Lauderdale, Florida, ARVO conference, May 2012, e-abstract #6109.